首页> 外文期刊>BMC Immunology >Insight into SNPs and epitopes of E protein of newly emerged genotype-I isolates of JEV from Midnapur, West Bengal, India
【24h】

Insight into SNPs and epitopes of E protein of newly emerged genotype-I isolates of JEV from Midnapur, West Bengal, India

机译:对印度西孟加拉邦米德纳布尔新出现的JEV基因型I分离株的SNP和E蛋白表位的了解

获取原文
           

摘要

Background Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes Japanese Encephalitis (JE) and Acute Encephalitis Syndrome (AES) in humans. Genotype-I (as co-circulating cases with Genotype-III) was isolated in 2010 (JEV28, JEV21) and then in 2011 (JEV45) from Midnapur district, West Bengal (WB) for the first time from clinical patients who were previously been vaccinated with live attenuated SA14-14-2 strain. We apply bioinformatics and immunoinformatics on sequence and structure of E protein for analysis of crucial substitutions that might cause the genotypic transition, affecting protein - function and altering specificity of epitopes. Results Although frequency of substitutions in E glycoprotein of JEV28, JEV21 and JEV45 isolates vary, its homologous patterns remain exactly similar as earlier Japan isolate (Ishikawa). Sequence and 3D model-structure based analyses of E protein show that only four of all substitutions are critical for genotype-I specific effect of which N103K is common among all isolates indicating its role in the transition of genotype-III to genotype-I. Predicted B-cell and T-cell epitopes are seen to harbor these critical substitutions that affect overall conformational stability of the protein. These epitopes were subjected to conservation analyses using a large set of the protein from Asian continent. Conclusions The study identifies crucial substitutions that contribute to the emergence of genotype-I. Predicted epitopes harboring these substitutions may alter specificity which might be the reason of reported failure of vaccine. Conservation analysis of these epitopes would be useful for design of genotype-I specific vaccine.
机译:背景技术日本脑炎病毒(JEV)是由蚊子传播的黄病毒,可在人类中引起日本脑炎(JE)和急性脑炎综合症(AES)。于2010年(JEV28,JEV21)和2011年(JEV45)从西孟加拉邦Midnapur区(WB)首次分离出基因型I(与基因型III并存)。已接种减毒活SA14-14-2株。我们在E蛋白的序列和结构上应用了生物信息学和免疫信息学,以分析可能引起基因型转变,影响蛋白功能和改变表位特异性的关键取代。结果尽管JEV28,JEV21和JEV45分离​​株的E糖蛋白取代频率不同,但其同源模式仍与日本早期分离株(Ishikawa)完全相似。对E蛋白的基于序列和3D模型结构的分析表明,所有取代中只有四个对于I型基因特异性作用至关重要,在所有分离物中N103K都很常见,这表明其在I型基因向I型基因转变中的作用。可以看到预测的B细胞和T细胞表位具有影响蛋白质总体构象稳定性的这些关键取代。这些表位使用来自亚洲大陆的大量蛋白质进行了保守性分析。结论该研究确定了促成基因型I出现的关键替代。带有这些取代的预测表位可能会改变特异性,这可能是报道的疫苗失败的原因。这些表位的保守性分析对于基因型-I特异性疫苗的设计将是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号